The prognostic utility of neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in carcinoma of unknown primary (CUP): An experience from a tertiary UK cancer centre
Scott, Julie-Anne Peters, Niamh Harman, C Mitchell, Claire L Conway, Alicia-Marie
Scott, Julie-Anne
Peters, Niamh
Harman, C
Mitchell, Claire L
Conway, Alicia-Marie
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Scott JA, Peters N, Harman C, Mitchell CL, Conway AM, Cook N. The prognostic utility of neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in carcinoma of unknown primary (CUP): An experience from a tertiary UK cancer centre. Annals of Oncology. 2022 Sep;33(7):S774-S. PubMed PMID: WOS:000866211600499.